Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Merck & Co., Inc. Director's Dealing 2020

May 6, 2020

284_dirs_2020-05-06_e8aabe54-0b11-4b58-b9e2-4f16b91c21f8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Merck & Co., Inc. (MRK)
CIK: 0000310158
Period of Report: 2020-05-04

Reporting Person: Karachun Rita A (Sr. VP Fince-Global Controller)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-04 Common Stock M 1212 $77.67 Acquired 26714.972 Direct
2020-05-04 Common Stock F 597 $77.67 Disposed 26117.972 Direct
2020-05-05 Common Stock M 3283 $76.86 Acquired 29400.972 Direct
2020-05-05 Common Stock F 1617 $76.86 Disposed 27783.972 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-04 Restricted Stock Unit $ M 1212 Disposed 2021-05-04 Common Stock (1212) Direct
2020-05-05 Restricted Stock Unit $ M 3283 Disposed 2020-05-05 Common Stock (3283) Direct

Footnotes

F1: Holdings include shares acquired in dividend reinvestment transactions.

F2: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.

F3: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/4/2019, 5/4/2020 and 5/4/2021.